| FLL32 |
Influence on apoptosis |
Western Blot |
2.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
4.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
6.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
8.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
2.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
p-STAT3 |
|
| FLL32 |
Influence on apoptosis |
Western Blot |
4.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
p-STAT3 |
|
| FLL32 |
Influence on apoptosis |
Western Blot |
6.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
p-STAT3 |
|
| FLL32 |
Influence on apoptosis |
Western Blot |
8.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
p-STAT3 |
|
| FLL32 |
Influence on apoptosis |
Western Blot |
2.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
STAT3 |
|
| FLL32 |
Influence on apoptosis |
Western Blot |
4.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
STAT3 |
|
| FLL32 |
Influence on apoptosis |
Western Blot |
6.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
STAT3 |
|
| FLL32 |
Influence on apoptosis |
Western Blot |
8.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
STAT3 |
|
| FLL32 |
Influence on apoptosis |
Western Blot |
2.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
4.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
6.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
8.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
2.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
4.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
6.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
8.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
|
|
